Brief: Sio Gene Therapies Q1 Loss Per Share $0.16
12/08/2021 12:38
Aug 12 (Reuters) - Sio Gene Therapies Inc SIOX.O :
* Q1 LOSS PER SHARE $0.16
* Q1 EARNINGS PER SHARE ESTIMATE $-0.18 -- REFINITIV IBES
DATA
* SIO GENE THERAPIES - STRONG CASH POSITION WITH $111
MILLION OF
CASH AND CASH EQUIVALENTS AS OF JUNE 30, 2021, PROVIDING CASH
RUNWAY INTO Q4 2022
Source text for Eikon: ID:nGNX8HcrlJ
Further company coverage: SIOX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sio Gene Therapies
See all newsBrief: Sio Gene Therapies Inc - On March 14, Got Notice That Nasdaq Has Determined That Company's Common Stock Will Be Delisted From Nasdaq Capital Market
Brief: Sio Gene Therapies Announces Fiscal Third Quarter 2022 Financial Results
Brief: Sio Gene Therapies Inc. Announces Board Approval Of Plan Of Complete Liquidation, Dissolution
Brief: Sio Gene Therapies Announces Second Quarter Financial Results
Brief: Sio Gene Therapies Announces Fiscal First Quarter 2022 Financial Results